recurrence of varicose veins
Conditions
Interventions
crossectomy vs ultrasound guided sclerofoam therapy
Sponsors
Amphia Ziekenhuis
Eligibility
Age
18 Years to 99 Years
Inclusion criteria
Inclusion criteria: Objective insufficiency (> 0.5 seconds on ultrasound examination) of the SSV after crossectomy (with or without stripping) with visible neovascularisation at the sapheno-popliteal junction
Exclusion criteria
Exclusion criteria: thrombosis (superficial or deep) or thrombotic disease
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Anatomical and/or hemodynamic success on ultrasound examination. Success is defined by the absence of reflux >0.5 seconds (with or without sclerus) in the SSV at 2 sites: the saphenopopliteal junction and halfway the calf (after 3, 12 months and 5 years). | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Number of additional UGFS treatments after the randomized treatment. 2. Number and type of additional treatments for varicosities in study limb. 3. Patient's satisfaction about the treatment (10-points scale, from very unsatisfied to very content) after 3 and 12 months. 4. Quality of life, measured with the SF-36 test on t=0, after 2 weeks and after 3 months. 5. Patient's reported complications (pain, hematoma, infection, paresthesia) and doctor's reported complications after 2 weeks (superficial and deep thrombosis, hyperpigmentation). | — |
Countries
Netherlands
Outcome results
None listed